Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Transitional Cell 14Urinary Bladder Neoplasms 13Colorectal Neoplasms 10Carcinoma, Merkel Cell 9Breast Neoplasms 9Carcinoma, Renal Cell 7Neoplasms 6Neoplasm Metastasis 6Carcinoma, Non-Small-Cell Lung 6Small Cell Lung Carcinoma 4Carcinoma, Hepatocellular 4Turcot syndrome 3Stomach Neoplasms 3Neuroendocrine Tumors 3Head and Neck Neoplasms 3Endometrial Neoplasms 3Urethral Neoplasms 2Ureteral Neoplasms 2Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Penile Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Melanoma 2Lung Neoplasms 2Glioblastoma 2Gastrointestinal Neoplasms 2Colonic Neoplasms 2Carcinoma, Squamous Cell 2Carcinoma, Neuroendocrine 2Uterine Cervical Neoplasms 1

Interventions

Cisplatin 88Fluorouracil 71Paclitaxel 69Radiotherapy 63Oxaliplatin 55Irinotecan 37Docetaxel 36Carboplatin 36Leucovorin 34Capecitabine 28Radiation 25Surgical Procedures, Operative 22Drug Therapy 19pembrolizumab 18Cetuximab 15Bevacizumab 15Nivolumab 14tislelizumab 12camrelizumab 11Neoadjuvant Therapy 11Esophagectomy 11Chemoradiotherapy 11S 1 (combination) 10Albumin-Bound Paclitaxel 10nimotuzumab 9Trastuzumab 9durvalumab 8Radiotherapy, Intensity-Modulated 8Gefitinib 7Epirubicin 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Esophageal Neoplasms × avelumab × Clear all
NCT03800953 2021-09-08

The Ave-CRT Study for Newly Diagnosed Metastatic Esophageal Squamous Cell Carcinoma

National Taiwan University Hospital

Phase 2 Unknown
26 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡